• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jaguar Health, Inc. - Common Stock (NQ:JAGX)

    2.960 -0.050 (-1.66%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 34,612
    Open 3.030
    Bid (Size) 2.770 (100)
    Ask (Size) 2.960 (100)
    Prev. Close 3.010
    Today's Range 2.810 - 3.030
    52wk Range 2.120 - 97.65
    Shares Outstanding 171,350,166
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
    From Jaguar Health, Inc.
    Via ACCESS Newswire

    Performance

    YTD
    -91.5%
    -91.5%
    1 Month
    -16.6%
    -16.6%
    3 Month
    -74.6%
    -74.6%
    6 Month
    -91.8%
    -91.8%
    1 Year
    -96.6%
    -96.6%

    More News

    Read More
    News headline image
    Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
    Via ACCESS Newswire
    News headline image
    Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders
    Via ACCESS Newswire
    News headline image
    Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders
    Via ACCESS Newswire
    News headline image
    Jaguar Health Compliant with Nasdaq Bid Price Rule
    Via ACCESS Newswire
    Jaguar Health Inc (NASDAQ:JAGX) Swings to Profit on Licensing Deal, But Market Sells the News ↗
    Via Chartmill
    News headline image
    Jaguar Health (JAGX) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Jaguar Health Reports First Quarter 2026 Financials
    Via ACCESS Newswire
    News headline image
    Jaguar (JAGX) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer
    Via ACCESS Newswire
    News headline image
    Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
    Via ACCESS Newswire
    News headline image
    Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
    Via ACCESS Newswire
    These stocks are moving in today's session ↗
    Via Chartmill
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Monday's session. ↗
    Via Chartmill
    News headline image
    Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health
    Via ACCESS Newswire
    News headline image
    Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs
    Via ACCESS Newswire
    News headline image
    Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
    Via ACCESS Newswire
    News headline image
    Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Jaguar Health, Inc. - Common Stock publicly traded?
    Yes, Jaguar Health, Inc. - Common Stock is publicly traded.
    What exchange does Jaguar Health, Inc. - Common Stock trade on?
    Jaguar Health, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Jaguar Health, Inc. - Common Stock?
    The ticker symbol for Jaguar Health, Inc. - Common Stock is JAGX on the Nasdaq Stock Market
    What is the current price of Jaguar Health, Inc. - Common Stock?
    The current price of Jaguar Health, Inc. - Common Stock is 2.960
    When was Jaguar Health, Inc. - Common Stock last traded?
    The last trade of Jaguar Health, Inc. - Common Stock was at 06/29/26 04:00 PM ET
    What is the market capitalization of Jaguar Health, Inc. - Common Stock?
    The market capitalization of Jaguar Health, Inc. - Common Stock is 507.20M
    How many shares of Jaguar Health, Inc. - Common Stock are outstanding?
    Jaguar Health, Inc. - Common Stock has 507M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.